惠陶集團(08238.HK)要求覆核上市委員會取消公司於港交所上市地位的決定
格隆匯9月26日丨惠陶集團(08238.HK)公佈,有關GEM上市委員會決定維持聯交所上市部根據GEM上市規則第9.04條暫停買賣公司股份的決定,並要求公司在12個月期限屆滿時重新遵守GEM上市規則第17.26條,倘公司未能符合上述規定,聯交所將取消公司的上市地位。
公司已於2019年9月26日向GEM上市(覆核)委員會遞交一份書面呈請,請求GEM上市(覆核)委員會根據GEM上市規則第四章對委員會決定進行覆核。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.